
Σταδιοποίηση σε Ca Παχέως Εντέρου
Ca Παχέως Εντέρου |
|||||||
AJCC Stages |
|||||||
Stages |
T |
N |
M |
Dukes1 |
MAC2 |
||
0 |
Tis |
N0 |
M0 |
- |
- |
||
I |
T1 |
N0 |
M0 |
A |
A |
||
T2 |
N0 |
M0 |
A |
B1 |
|||
IIA |
T3 |
N0 |
M0 |
B |
B2 |
||
IIB |
T4a |
N0 |
M0 |
B |
B2 |
||
IIC |
T4b |
N0 |
M0 |
B |
B3 |
||
IIIA |
T1-T2 |
N1/N1c |
M0 |
C |
C1 |
||
T1 |
N2a |
M0 |
C |
C1 |
|||
IIIB |
T3-T4a |
N1/N1c |
M0 |
C |
C2 |
||
T2-T3 |
N2a |
M0 |
C |
C1/C2 |
|||
T1-T2 |
N2b |
M0 |
C |
C1 |
|||
IIIC |
T4a |
N2a |
M0 |
C |
C2 |
||
T3-T4a |
N2b |
M0 |
C |
C2 |
|||
T4b |
N1-N2 |
M0 |
C |
C3 |
|||
IVA |
Any T |
Any N |
M1a |
D |
D |
||
IVB |
Any T |
Any N |
M1b |
D |
D |
||
¹Dukes B is a composite of better (T3 N0 M0) and worse (T4 N0 M0) prognostic groups, as is Dukes C (Any T N1 M0 and Any T N2 M0). |
|||||||
(T) Primary Tumor |
|||||||
TX |
Primary tumor cannot be assessed |
||||||
T0 |
No evidence of primary tumor |
||||||
Tis |
Carcinoma in situ: Intraepithelial or invasion of lamina propria¹ |
||||||
T1 |
Tumor invades submucosa |
||||||
T2 |
Tumor invades muscularis propria |
||||||
T3 |
Tumor invades through muscularis propria into perirectal tissues |
||||||
T4a |
Tumor penetrates to surface of visceral peritoneum² |
||||||
T4b |
Tumor directly invades or is adherent to other organs or structures²,³ |
||||||
TX |
Primary tumor cannot be assessed |
||||||
¹Tis includes cancer cells confined within the glandular basement membrane (intraepithelial) or mucosal lamina propria (intramucosal) with no extension through the muscularis mucosae into the submucosa. |
|||||||
(N) Regional Lymph Nodes |
|||||||
NX |
Regional lymph nodes cannot be assessed |
||||||
N0 |
No regional lymph node metastasis |
||||||
N1 |
Metastasis in 1-3 regional lymph nodes |
||||||
N1a |
Metastasis in 1 regional lymph node |
||||||
N1b |
Metastasis in 2-3 regional lymph nodes |
||||||
N1c |
Tumor deposit(s) in subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional nodal metastasis |
||||||
N2 |
Metastasis in ≥ 4 regional lymph nodes |
||||||
N2a |
Metastasis in 4-6 regional lymph nodes |
||||||
N2b |
Metastasis in ≥ 7 lymph nodes |
||||||
(M) Distant Metastasis |
|||||||
M0 |
No distant metastasis |
||||||
M1 |
Distant metastasis |
||||||
M1a |
Metastasis confined to 1 organ or site (e.g., liver, lung, ovary, nonregional node) |
||||||
M1b |
Metastases in > 1 organ/site or the peritoneum |
||||||
(G) Histologic Grade |
|||||||
GX |
Grade cannot be assessed |
||||||
G1 |
Well differentiated |
||||||
G2 |
Moderately differentiated |
||||||
G3 |
Poorly differentiated |
||||||
G4 |
Undifferentiated |
||||||
*G1-G2 can be designated low grade. G3-G4 as high grade may contribute to overall outcome independent of TNM staging. |
|||||||
Χαρακτηριστικά Επέκτασης |
|||||||
Local
Lymphatic
|
Hematogenous
|
||||||
Κατηγοριοποίηση (Ιστολογικοί Τύποι) |
|||||||
Applies only to colorectal carcinomas
Histological types
|
|